People often ask whether Ozempic helps them lose weight. Clinical trials have shown reductions in body weight among adults ...

Discover the serious yet rare side effects of Ozempic, including pancreatitis, thyroid cancer, gallbladder issues, kidney injury, and allergic reactions, plus expert insights.

Question: I am a woman with a BMI of 31 and have recently been put on statins for high cholesterol. I have also been told ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Novo Nordisk A/S: Ozempic® receives EU recommendation in peripheral arterial disease, cementing the broad benefits of semaglutide for people with type 2 diabetes and comorbidities ...

Ozempic is the only GLP-1 RA indicated to reduce the risk of worsening kidney disease and risk of death from CV events in adults with type 2 diabetes and CKD. Ozempic is currently marketed in 72 ...

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...

The 61-year-old man received a new kidney from a deceased donor after being diagnosed with “nephrosclerosis-related end-stage ...

A study found another potential benefit of the weight loss drugs: lowered risk of chronic conditions. GLP-1 agonist medications such as Ozempic and Wegovy are in high demand, largely due to their ...

Ozempic is also approved for reducing the risk of major adverse cardiovascular events in adults with T2D mellitus, established cardiovascular disease and chronic kidney disease.

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure increasing danger of macular degeneration.

Both Wegovy and Ozempic are semaglutide – a drug that first entered the US market in 2017 as a diabetes medication. It was ...